Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis

Published:2018-07-24 Issue:9 Volume:70 Page:1419-1428
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Kjelgaard-Petersen Cecilie F.¹²^ORCID,Platt Adam³,Braddock Martin⁴,Jenkins Martin A.³,Musa Kishwar²,Graham Emma³,Gantzel Thorbjørn⁵,Slynn Gillian⁴,Weinblatt Michael E.⁶,Karsdal Morten A.²,Thudium Christian S.²,Bay-Jensen Anne-C.²

Affiliation:

1. Technical University of Denmark; Kongens Lyngby; Denmark

2. Nordic Bioscience; Herlev Denmark

3. AstraZeneca; Cambridge UK

4. AstraZeneca; Macclesfield UK

5. Gentofte University Hospital; Gentofte Denmark

6. Brigham and Women's Hospital; Boston Massachusetts

Funder

AstraZeneca

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40527/fullpdf

Reference54 articles.

1. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I;Helmick;Arthritis Rheum,2008

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

3. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Rheumatol,2016

4. Clinical development success rates for investigational drugs [review];Hay;Nat Biotechnol,2014

5. Rheumatoid arthritis: threshold for success in RA drug development [review];Cohen;Nat Rev Rheumatol,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of biochemical markers with bone marrow lesion changes on imaging—data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium;Arthritis Research & Therapy;2024-01-18

2. Use of extracellular matrix biomarkers in clinical research;Biochemistry of Collagens, Laminins and Elastin;2024

3. An Update on the Emerging Role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis;Current Drug Targets;2023-12

4. Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2);Rheumatology and Therapy;2022-03-30

5. A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritis;Osteoarthritis and Cartilage Open;2021-12